+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Analysis Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Consumables, Instruments), By Technique (Flow Cytometry, Cell Microarrays), By Process (Cell Interaction, Single-cell Analysis), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5990582
REQUEST CUSTOMIZATION
Description Jump to:
The global cell analysis market size was estimated at USD 31.59 billion in 2024 and is projected to grow at a CAGR of 10.03% from 2025 to 2030. This growth can be attributed to the increasing prevalence of chronic diseases, advancements in cell analysis technologies, and the growing number of drug discovery activities. Cell analysis has emerged as an important tool for the identification of potential therapies and treatments for chronic diseases. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, autoimmune diseases, neurological disorders, and others can drive the demand for cell analysis. According to the American Cancer Society, over 2 million new cancer cases are expected to be diagnosed in the U.S. in 2024.

Cell analysis has witnessed an increase in its application, from early-stage cancer diagnostics to the development of cancer-associated therapies and tools, which has further increased its popularity in the oncology sector. The players operating in the oncology sector are increasing their efforts for advancements in cell analysis to develop advanced therapies and treatments. For instance, in March 2024, a cancer diagnostics company, Serum Detect, was set to launch the T-cell analysis approach for early cancer detection at the American Association for Cancer Research (AACR). Such increasing efforts by healthcare companies to increase the application of cell analysis are anticipated to drive market growth over the forecast period.

Moreover, technological advancements in cell analysis have enabled the development of automated cell analysis systems that offer results with better accuracy and efficiency. Similarly, the development of advanced technologies such as automated cell imaging, cell counting, and cell sorters allows researchers to study cells on a much larger scale. For instance, in July 2024. NanoCellect Biomedical announced the launch of VERLO, an image-guided cell sorter. This cell-sorter allows the researchers to distinguish & sort interacting cells, enabling precise characterization of cell subsets & validation of their functional phenotypes without disturbing the cell interactions. Such advancements in cell analysis technologies are anticipated to increase demand and drive market growth over the forecast period.

In addition to this, the adoption of cell cycle analysis has significantly increased in drug discovery to analyze the associated complexities. Similarly, the increasing advancements in cell biology, molecular biology, bioinformatics, proteomics, and genomics have increased the significance of utilizing cell-based assays in the drug development process. Cell-based assays offer an alternative approach to the conventional methods of toxicity and drug safety testing and allow researchers to identify problems with tested compounds in early screening through cytotoxicity and cell deaths. Thus, the increasing drug discovery activities owing to the rising need for advanced treatments are anticipated to increase the demand for cell-based assays, thereby driving the market growth.

Global Cell Analysis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global cell analysis market report based on product & service, technique, process, end-use, and region.

Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

  • Reagents & Consumables
  • Instruments
  • Accessories
  • Software
  • Service

Technique Outlook (Revenue, USD Million, 2018 - 2030)

  • Flow Cytometry
  • PCR
  • Cell Microarrays
  • Microscopy
  • Spectrophotometry
  • High Content-Screening
  • Other Techniques

Process Outlook (Revenue, USD Million, 2018 - 2030)

  • Cell Identification
  • Cell Viability
  • Cell Signaling Pathways
  • Cell Proliferation
  • Cell Counting
  • Cell Interaction
  • Cell Structure Study
  • Single-cell Analysis
  • Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinical Testing Laboratories
  • Academic & Research Institutes
  • Other

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Technique Segment
1.2.3. Process Segment
1.2.4. End use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Cell Analysis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases
3.2.1.2. Advancements in cell analysis technologies
3.2.1.3. Growing number of drug discovery activities
3.2.2. Market restraint analysis
3.2.2.1. Complexity of cell analysis techniques
3.3. Cell Analysis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Cell Analysis Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Cell Analysis Market Product & Service Movement Analysis
4.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Reagents & Consumables
4.4.1. Reagents & Consumables market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Instruments
4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Accessories
4.6.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Software
4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Service
4.8.1. Service market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Cell Analysis Market: Technique Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Cell Analysis Market Technique Movement Analysis
5.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
5.4. Flow Cytomtery
5.4.1. Flow Cytomtery market estimates and forecasts 2018 to 2030 (USD Million)
5.5. PCR
5.5.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Cell Microarrays
5.6.1. Cell Microarrays market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Microscopy
5.7.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Spectrophotometry
5.8.1. Spectrophotometry market estimates and forecasts 2018 to 2030 (USD Million)
5.9. High Content-Screening
5.9.1. High Content-Screening market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Other Techniques
5.10.1. Other Techniques market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Cell Analysis Materials Market: Process Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Cellular Starting Materials Market Process Movement Analysis
6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
6.4. Cell Identification
6.4.1. Cell Identification market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Cell Viability
6.5.1. Cell Viability market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Cell Signaling Pathways
6.6.1. Cell Signaling Pathwaysmarket estimates and forecasts 2018 to 2030 (USD Million)
6.7. Cell Proliferation
6.7.1. Cell Proliferation market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Cell Counting
6.8.1. Cell Counting market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Cell Interaction
6.9.1. Cell Interaction market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Cell Structure Study
6.10.1. Cell Structure Study market estimates and forecasts 2018 to 2030 (USD Million)
6.11. Single-cell Analysis
6.11.1. Single-cell Analysis market estimates and forecasts 2018 to 2030 (USD Million)
6.12. Others
6.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Cellular Starting Materials Market: End use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Cellular Starting Materials Market End use Movement Analysis
7.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Hospitals & Clinical Testing Laboratories
7.5.1. Hospitals & Clinical Testing Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Other
7.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Cell Analysis Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Target disease prevalence
8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Target disease prevalence
8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Competitive scenario
8.4.4.3. Regulatory framework
8.4.4.4. Target disease prevalence
8.4.4.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Target disease prevalence
8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Target disease prevalence
8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Target disease prevalence
8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Target disease prevalence
8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Target disease prevalence
8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Target disease prevalence
8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Competitive scenario
8.5.8.3. Regulatory framework
8.5.8.4. Target disease prevalence
8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Competitive scenario
8.5.9.3. Regulatory framework
8.5.9.4. Target disease prevalence
8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Target disease prevalence
8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Target disease prevalence
8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory framework
8.6.4.4. Target disease prevalence
8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory framework
8.6.5.4. Target disease prevalence
8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Regulatory framework
8.6.6.4. Target disease prevalence
8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Competitive scenario
8.6.7.3. Target disease prevalence
8.6.7.4. Regulatory framework
8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
8.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Target disease prevalence
8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Target disease prevalence
8.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
8.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Regulatory framework
8.8.2.4. Target disease prevalence
8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Competitive scenario
8.8.3.3. Regulatory framework
8.8.3.4. Target disease prevalence
8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Competitive scenario
8.8.4.3. Regulatory framework
8.8.4.4. Target disease prevalence
8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Competitive scenario
8.8.5.3. Regulatory framework
8.8.5.4. Target disease prevalence
8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific, Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Danaher
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. BD
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Merck KGaA
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Agilent Technologies, Inc.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Bio-Rad Laboratories, Inc.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Miltenyl Biotech
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Revvity
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. New England Biolabs
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Avantor, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global cell analysis market, by region, 2018 - 2030 (USD Million)
Table 3 Global cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 4 Global cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 5 Global cell analysis market, by process, 2018 - 2030 (USD Million)
Table 6 Global cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America cell analysis market, by country, 2018 - 2030 (USD Million)
Table 8 North America cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 9 North America cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 10 North America cell analysis market, by process, 2018 - 2030 (USD Million)
Table 11 North America cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 12 U.S. cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 13 U.S. cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 14 U.S. cell analysis market, by process, 2018 - 2030 (USD Million)
Table 15 U.S. cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 16 Canada cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 17 Canada cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 18 Canada cell analysis market, by process, 2018 - 2030 (USD Million)
Table 19 Canada cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 20 Mexico cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 21 Mexico cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 22 Mexico cell analysis market, by process, 2018 - 2030 (USD Million)
Table 23 Mexico cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 24 Europe cell analysis market, by country, 2018 - 2030 (USD Million)
Table 25 Europe cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 26 Europe cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 27 Europe cell analysis market, by process, 2018 - 2030 (USD Million)
Table 28 Europe cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 29 Germany cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 30 Germany cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 31 Germany cell analysis market, by process, 2018 - 2030 (USD Million)
Table 32 Germany cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 33 UK cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 34 UK cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 35 UK cell analysis market, by process, 2018 - 2030 (USD Million)
Table 36 UK cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 37 France cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 38 France cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 39 France cell analysis market, by process, 2018 - 2030 (USD Million)
Table 40 France cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 41 Italy cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 42 Italy cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 43 Italy cell analysis market, by process, 2018 - 2030 (USD Million)
Table 44 Italy cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 45 Spain cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 46 Spain cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 47 Spain cell analysis market, by process, 2018 - 2030 (USD Million)
Table 48 Spain cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 49 Denmark cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 50 Denmark cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 51 Denmark cell analysis market, by process, 2018 - 2030 (USD Million)
Table 52 Denmark cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 53 Sweden cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 54 Sweden cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 55 Sweden cell analysis market, by process, 2018 - 2030 (USD Million)
Table 56 Sweden cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 57 Norway cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 58 Norway cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 59 Norway cell analysis market, by process, 2018 - 2030 (USD Million)
Table 60 Norway cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 61 Asia Pacific cell analysis market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 63 Asia Pacific cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 64 Asia Pacific cell analysis market, by process, 2018 - 2030 (USD Million)
Table 65 Asia Pacific cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 66 China cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 67 China cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 68 China cell analysis market, by process, 2018 - 2030 (USD Million)
Table 69 China cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 70 Japan cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 71 Japan cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 72 Japan cell analysis market, by process, 2018 - 2030 (USD Million)
Table 73 Japan cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 74 India cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 75 India cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 76 India cell analysis market, by process, 2018 - 2030 (USD Million)
Table 77 India cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 78 South Korea cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 79 South Korea cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 80 South Korea cell analysis market, by process, 2018 - 2030 (USD Million)
Table 81 South Korea cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 82 Australia cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 83 Australia cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 84 Australia cell analysis market, by process, 2018 - 2030 (USD Million)
Table 85 Australia cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 86 Thailand cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 87 Thailand cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 88 Thailand cell analysis market, by process, 2018 - 2030 (USD Million)
Table 89 Thailand cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 90 Latin America cell analysis market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 92 Latin America cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 93 Latin America cell analysis market, by process, 2018 - 2030 (USD Million)
Table 94 Latin America cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 95 Brazil cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 96 Brazil cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 97 Brazil cell analysis market, by process, 2018 - 2030 (USD Million)
Table 98 Brazil cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 99 Argentina cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 100 Argentina cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 101 Argentina cell analysis market, by process, 2018 - 2030 (USD Million)
Table 102 Argentina cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 103 MEA cell analysis market, by country, 2018 - 2030 (USD Million)
Table 104 MEA cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 105 MEA cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 106 MEA cell analysis market, by process, 2018 - 2030 (USD Million)
Table 107 MEA cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 108 South Africa cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 109 South Africa cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 110 South Africa cell analysis market, by process, 2018 - 2030 (USD Million)
Table 111 South Africa cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia cell analysis market, by process, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 116 UAE cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 117 UAE cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 118 UAE cell analysis market, by process, 2018 - 2030 (USD Million)
Table 119 UAE cell analysis market, by end-use, 2018 - 2030 (USD Million)
Table 120 Kuwait cell analysis market, by product & service, 2018 - 2030 (USD Million)
Table 121 Kuwait cell analysis market, by technique, 2018 - 2030 (USD Million)
Table 122 Kuwait cell analysis market, by process, 2018 - 2030 (USD Million)
Table 123 Kuwait cell analysis market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Cell Analysis market: Market outlook
Fig. 5 Cell Analysis market: Segment outlook
Fig. 6 Cell Analysis market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Cell Analysis market driver impact
Fig. 9 Cell Analysis market restraint impact
Fig. 10 Cell Analysis market: Product & Service outlook and key takeaways
Fig. 11 Cell Analysis market: Product & Service movement analysis
Fig. 12 Reagents & consumables market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 13 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Software market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Service market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Cell Analysis market: Technique outlook and key takeaways
Fig. 18 Cell Analysis market: Technique movement analysis
Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Cell microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Microscopy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Spectrophotometry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 High content-screening market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Other techniques market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Cell Analysis market: Process outlook and key takeaways
Fig. 27 Cell Analysis market: Process movement analysis
Fig. 28 Cell identification market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Cell viability market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Cell Signaling Pathwaysmarket estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Cell proliferation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Cell counting market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Cell interaction market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Cell structure study market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Single-cell analysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Cell Analysis market: End use outlook and key takeaways
Fig. 38 Cell Analysis market: End use movement analysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Hospitals & clinical testing laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Other market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Global Cell Analysis market: Regional outlook and key takeaways
Fig. 44 Global Cell Analysis market: Regional movement analysis
Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Target Disease Prevalence
Fig. 49 Key country dynamics
Fig. 50 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Target Disease Prevalence
Fig. 52 Key country dynamics
Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Target Disease Prevalence
Fig. 55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Target Disease Prevalence
Fig. 59 Key country dynamics
Fig. 60 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Target Disease Prevalence
Fig. 62 Key country dynamics
Fig. 63 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Target Disease Prevalence
Fig. 65 Key country dynamics
Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Target Disease Prevalence
Fig. 68 Key country dynamics
Fig. 69 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Target Disease Prevalence
Fig. 71 Key country dynamics
Fig. 72 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Target Disease Prevalence
Fig. 74 Key country dynamics
Fig. 75 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Target Disease Prevalence
Fig. 77 Key country dynamics
Fig. 78 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Target Disease Prevalence
Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Target Disease Prevalence
Fig. 84 Key country dynamics
Fig. 85 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Target Disease Prevalence
Fig. 87 Key country dynamics
Fig. 88 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Target Disease Prevalence
Fig. 90 Key country dynamics
Fig. 91 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Target Disease Prevalence
Fig. 93 Key country dynamics
Fig. 94 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Target Disease Prevalence
Fig. 96 Key country dynamics
Fig. 97 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Target Disease Prevalence
Fig. 99 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Target Disease Prevalence
Fig. 103 Key country dynamics
Fig. 104 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Target Disease Prevalence
Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Target Disease Prevalence
Fig. 110 Key country dynamics
Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Target Disease Prevalence
Fig. 113 Key country dynamics
Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Target Disease Prevalence
Fig. 116 Key country dynamics
Fig. 117 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Target Disease Prevalence

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Danaher
  • BD
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Miltenyl Biotech
  • Revvity
  • New England Biolabs
  • Avantor, Inc.

Table Information

Report AttributeDetails
No. of Pages120
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 31.59 Billion
Forecasted Market Value ( USD ) by 2030 $ 55.3 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

3D Cell Analysis Software Market - Global Forecast 2025-2030 - Product Image

3D Cell Analysis Software Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Microfluidic Single-Cell Analysis & Screening System Market - Global Forecast 2025-2030 - Product Image

Microfluidic Single-Cell Analysis & Screening System Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030 - Product Image

Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030

  • Report
  • 518 Pages
  • Global
From
Cell Analysis Market Report by Product, Analysis Type, Techniques, End-User, and Region 2025-2033 - Product Image

Cell Analysis Market Report by Product, Analysis Type, Techniques, End-User, and Region 2025-2033

  • Report
  • 139 Pages
  • Global
From
Cell Analysis - Global Strategic Business Report - Product Image

Cell Analysis - Global Strategic Business Report

  • Report
  • 273 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.